Is the combination of interfascial plane blocks sufficient for awake breast cancer surgery? An observational, prospective, proof-of-concept study

被引:1
|
作者
Ertas, Gamze [1 ]
Cakmak, Hamiyet Senol [1 ]
Ocak, Sonmez [2 ]
Yilmaz, Mert [1 ]
Ozdemir, Dursun Burak [2 ]
Tulgar, Serkan [1 ]
机构
[1] Samsun Univ, Samsun Training & Res Hosp, Dept Anesthesiol & Reanimat, Fac Med, Baris Bulvari Kadikoy Mahallesi 199 PK, TR-55090 Ilkadim, Samsun, Turkiye
[2] Samsun Univ, Samsun Training & Res Hosp, Dept Gen Surg, Fac Med, Samsun, Turkiye
来源
BMC ANESTHESIOLOGY | 2024年 / 24卷 / 01期
关键词
Regional anaesthesia; Breast surgery; Nerve block; Awake surgery; Plane blocks; THORACIC WALL BLOCKS; ERECTOR SPINAE; ANESTHESIA; SERRATUS;
D O I
10.1186/s12871-024-02725-0
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Introduction Breast cancer is the most prevalent cancer among women, often necessitating surgical intervention. While surgeries like lumpectomy can be performed under local anesthesia, more extensive procedures typically require general anesthesia. Awake breast cancer surgery has emerged as an alternative due to risks associated with general anesthesia and patient preference. Methods This prospective observational study, conducted from July 2022 to July 2023, evaluated the effectiveness of ultrasound-guided fascial plane blocks for awake breast surgery. Patients aged 18-80 years undergoing unilateral breast surgery were included, following ethical committee approval and written informed consent. Exclusion criteria were prior breast surgery, coagulopathies, infections, allergies to local anesthetics, psychiatric disorders, body mass index over 40 kg/m(2), and chest deformities. The combination of interpectoral, pecto-serratus, and deep serratus plane blocks was used as the primary anesthetic method, with a superficial parasternal block added in cases where complete cutaneous coverage was not achieved. Results Seventeen patients were enrolled. The primary outcome, sufficient surgical anesthesia without deep sedation, was achieved in 15 patients. The combination of the aforementioned blocks proved effective, with an average surgery duration of 59.66 min, and propofol requirements averaging 1.77 mg/kg/hour. Most patients reported high satisfaction levels, and no early or late block-related complications were observed. Conclusion The combination of fascial plane blocks is a viable option for awake breast cancer surgery, potentially eliminating the need for more invasive anesthesia techniques. Further studies are necessary to confirm these findings in larger, homogeneous patient groups.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept study
    Drury, Suzanne
    Salter, Janine
    Baehner, Frederick L.
    Shak, Steven
    Dowsett, Mitch
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (06) : 513 - 517
  • [32] Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients
    Marjolijn M. Ladan
    Titia G. Meijer
    Nicole S. Verkaik
    Cecile de Monye
    Linetta B. Koppert
    Esther Oomen-de Hoop
    Carolien H. M. van Deurzen
    Roland Kanaar
    Julie Nonnekens
    Dik C. van Gent
    Agnes Jager
    npj Breast Cancer, 9
  • [33] Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study
    Lampert, Erika J.
    Zimmer, Alexandra
    Padget, Michelle
    Cimino-Mathews, Ashley
    Nair, Jayakumar R.
    Liu, Yingmiao
    Swisher, Elizabeth M.
    Hodge, James W.
    Nixon, Andrew B.
    Nichols, Erin
    Bagheri, Mohammad H.
    Levy, Elliott
    Radke, Marc R.
    Lipkowitz, Stanley
    Annunziata, Christina M.
    Taube, Janis M.
    Steinberg, Seth M.
    Lee, Jung-Min
    CLINICAL CANCER RESEARCH, 2020, 26 (16) : 4268 - 4279
  • [34] Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study
    Griesinger, G.
    von Otte, S.
    Schroer, A.
    Ludwig, A. K.
    Diedrich, K.
    Al-Hasani, S.
    Schultze-Mosgau, A.
    HUMAN REPRODUCTION, 2007, 22 (05) : 1348 - 1352
  • [35] Findings from the first prospective womb to breast cancer study: New gestational biomarkers support proof of concept that gestation is a window of susceptibility for the breast
    Cohn, Barbara
    Krigbaum, Nickilou
    Zimmermann, Lauren
    Cirillo, Piera
    CANCER RESEARCH, 2015, 75
  • [36] Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study
    Habib, Ashraf S.
    Kertai, Miklos D.
    Cooter, Mary
    Greenup, Rachel A.
    Hwang, Shelley
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2019, 44 (02) : 192 - 199
  • [37] Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells
    Campos, Javier
    Varas-Godoy, Manuel
    Samir Haidar, Ziyad
    NANOMEDICINE, 2017, 12 (05) : 473 - 490
  • [38] Home self-testing of complete blood counts in patients with breast cancer during chemotherapy: A proof-of-concept cohort study in e-oncology
    Friis-Hansen, Lennart
    Bjorck, Pippi Jonassen
    Hartvig, Ditte
    Andresene, Susanne
    Rasmussena, Berit
    Hansena, Christina
    Nistrup, Anne
    Hundewadt, Keld
    Hollander, Niels Henrik
    ACTA ONCOLOGICA, 2024, 63
  • [39] A proof-of-concept study of LXP5268 as an add-on neoadjuvant chemotherapy in patients with early-stage triple-negative breast cancer
    Liu, Liang Chih, Sr.
    Way, Tzong-Der
    Lin, Chin-Hua
    Chen, Ya-Hui
    Kuo, Pin-Hung
    Tseng, Chung-Hsin
    Chen, Chiu-Heng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)